Vimarsana
Biggest News Aggregation in the World

Cell Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Therapeutics Today - Breaking & Trending Today

Analyzing BriaCell Therapeutics (OTCMKTS:BCTXF) and Applied Therapeutics (NASDAQ:APLT) - Vimarsana News

Analyzing BriaCell Therapeutics (OTCMKTS:BCTXF) and Applied Therapeutics (NASDAQ:APLT)

Applied Therapeutics (NASDAQ:APLT – Get Free Report) and BriaCell Therapeutics (OTCMKTS:BCTXF – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations and institutional ownership. Earnings & Valuation This table compares Applied […]

BriaCell Therapeutics (NASDAQ:BCTX) Earns "Buy" Rating from HC Wainwright - Vimarsana News

BriaCell Therapeutics (NASDAQ:BCTX) Earns "Buy" Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of BriaCell Therapeutics (NASDAQ:BCTX – Free Report) in a report published on Friday, Benzinga reports. They currently have a $18.00 price objective on the stock. BriaCell Therapeutics Stock Performance Shares of BCTX opened at $1.44 on Friday. The stock has a fifty day moving average price of […]

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Receives New Coverage from Analysts at StockNews.com - Vimarsana News

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research note released on Friday. The brokerage issued a hold rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Stock Performance Shares of NASDAQ BCLI opened at $0.54 on Friday. The firm has a market cap of $37.65 million, a […]

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Coverage Initiated by Analysts at StockNews.com - Vimarsana News

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research report sent to investors on Friday. The firm issued a hold rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Trading Down 7.0 % Shares of NASDAQ BCLI opened at $0.54 on Friday. The firm has a 50 day […]

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update - Vimarsana News

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update

BriaCell Therapeutics Corp. (NASDAQ:BCTXW – Get Free Report) saw a significant decline in short interest in the month of May. As of May 15th, there was short interest totalling 100 shares, a decline of 95.8% from the April 30th total of 2,400 shares. Based on an average daily volume of 41,000 shares, the days-to-cover ratio […]